First-in-class drug candidate (MPH-220) efficiently improves spastic gait disorders by selective inhibition of fast skeletal muscle myosin-2

• DOI: 10.1016/j.bpj.2021.11.1291
• Publication Date: 2022-02-11T13:18:03Z
• Authors: Mate Gyimesi; Adam I. Horvath; Demeter Turos; Sharad Kumar Suthar; Mate Penzes; Louise Canon; Carlos Kikuti; Kathleen Ruppel; Darshan V. Trivedi; James A. Spudich; Anna Á. Rauscher; Mihaly Kovacs; Samuel Komoly; Anne M. Houdusse; Andras Malnasi-Cs...
• Keywords: Stroke